InvestorsHub Logo
Followers 21
Posts 1996
Boards Moderated 0
Alias Born 11/26/2014

Re: JMoriarty post# 3353

Thursday, 07/26/2018 4:14:40 PM

Thursday, July 26, 2018 4:14:40 PM

Post# of 4159
Funding shouldn't be required for approval.

For the trial to start they may need to have a year funded.

So your talking about 10 million less government grants These numbers will work out and the chart supports the market confidence in that happening.

__________________________________________________________________________

Theralase Researchers Receive Government Grant



Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a clinical-stage pharmaceutical company dedicated to the research and development of light-activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations used to safely and effectively destroy cancer is pleased to announce that Theralase researchers; specifically: University Health Network (“UHN”) and the University of Toronto (“UT”) have received an Ontario Research Fund – Research Excellence (“ORF-RE”) grant with a primary mandate of advancing personalized Anti-Cancer Photo Dynamic Therapy (“PDT”) for each individual cancer patient to safely and effectively destroy their particular cancer, while maintaining the highest possible quality of life for them.



UHN and UT were successfully awarded an ORF-RE grant valued at $CAN 4.5 million, with financial and technical support provided by world-class industrial and institutional partners, such as: IBM Canada, Altera (Intel), Theralase and Companion Healthcare Corporation (“CHC”), further supported with funding from the Ontario government’s Ministry of Research and Innovation and Science.